Authors: TURMAN CN HUMPHREY SJ CURRY JT HARRIS LT ESCANDON NA MCCALL RB

Citation: Cn. Turman et al., A RAT MODEL OF SYMPATHOMIMETIC CARDIOVASCULAR POTENTIATION WITH TYPE-A MONOAMINE-OXIDASE INHIBITORS, The FASEB journal, 11(3), 1997, pp. 2823-2823

Authors: MCCALL RB ESCANDON NA HARRIS LT CLEMENT ME

Citation: Rb. Mccall et al., RAPID AND LONG-DURATION TOLERANCE TO THE VAGAL BRADYCARDIAC EFFECTS OF 5-HT1A RECEPTOR AGONISTS, Behavioural brain research, 73(1-2), 1995, pp. 297-300

Authors: MCCALL RB ESCANDON NA HARRIS LT CLEMENT ME

Citation: Rb. Mccall et al., TOLERANCE DEVELOPMENT TO THE VAGAL-MEDIATED BRADYCARDIA PRODUCED BY 5-HT1A RECEPTOR AGONISTS, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 776-781

Authors: ESCANDON NA ZIMMERMANN DC MCCALL RB

Citation: Na. Escandon et al., CHARACTERIZATION OF THE SEROTONIN(1A) RECEPTOR ANTAGONIST ACTIVITY OFWAY-100135 AND SPIPERONE, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 441-447